Great ann by VHL:
Virax Completes Acquisition of US Specialty Oncology
Company and Novel Cancer Drug Candidate
HIGHLIGHTS
? Pathway Oncology acquisition finalised with Virax taking exclusive worldwide license to valuable drug candidate GGTI-2418
? Virax becomes mid-clinical stage oncology company, with Phase 2 clinical program expected 2015/16
? Overwhelming shareholder support for all scrip acquisition to be paid in three tranches
? High calibre international biotechnology executive Paul Hopper joins board as executive director
- Forums
- ASX - Day Trading
- daytrading may 30 afternoon
daytrading may 30 afternoon, page-63
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online